These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 29513752

  • 1. Anti-cancer characteristics and ototoxicity of platinum(II) amine complexes with only one leaving ligand.
    Monroe JD, Hruska HL, Ruggles HK, Williams KM, Smith ME.
    PLoS One; 2018; 13(3):e0192505. PubMed ID: 29513752
    [Abstract] [Full Text] [Related]

  • 2. Phenanthriplatin, a monofunctional DNA-binding platinum anticancer drug candidate with unusual potency and cellular activity profile.
    Park GY, Wilson JJ, Song Y, Lippard SJ.
    Proc Natl Acad Sci U S A; 2012 Jul 24; 109(30):11987-92. PubMed ID: 22773807
    [Abstract] [Full Text] [Related]

  • 3. The Influence of the Auxiliary Ligand in Monofunctional Pt(II) Anticancer Complexes on the DNA Backbone.
    Tagari EV, Sifnaiou E, Tsolis T, Garoufis A.
    Int J Mol Sci; 2024 Jun 13; 25(12):. PubMed ID: 38928230
    [Abstract] [Full Text] [Related]

  • 4. The monofunctional platinum(II) compounds, phenanthriplatin and pyriplatin, modulate apoptosis signaling pathways in HEI-OC1 auditory hybridoma cells.
    Monroe JD, Johnston AM, Smith ME.
    Neurotoxicology; 2020 Jul 13; 79():104-109. PubMed ID: 32413439
    [Abstract] [Full Text] [Related]

  • 5. RNA-Seq Analysis of Cisplatin and the Monofunctional Platinum(II) Complex, Phenanthriplatin, in A549 Non-Small Cell Lung Cancer and IMR90 Lung Fibroblast Cell Lines.
    Monroe JD, Moolani SA, Irihamye EN, Speed JS, Gibert Y, Smith ME.
    Cells; 2020 Dec 08; 9(12):. PubMed ID: 33302475
    [Abstract] [Full Text] [Related]

  • 6. Rationalization of the Superior Anticancer Activity of Phenanthriplatin: An In-Depth Computational Exploration.
    Dabbish E, Russo N, Sicilia E.
    Chemistry; 2020 Jan 02; 26(1):259-268. PubMed ID: 31614021
    [Abstract] [Full Text] [Related]

  • 7. Nucleotide Binding Preference of the Monofunctional Platinum Anticancer-Agent Phenanthriplatin.
    Riddell IA, Johnstone TC, Park GY, Lippard SJ.
    Chemistry; 2016 May 23; 22(22):7574-81. PubMed ID: 27111128
    [Abstract] [Full Text] [Related]

  • 8. cis-Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects.
    Lovejoy KS, Todd RC, Zhang S, McCormick MS, D'Aquino JA, Reardon JT, Sancar A, Giacomini KM, Lippard SJ.
    Proc Natl Acad Sci U S A; 2008 Jul 01; 105(26):8902-7. PubMed ID: 18579768
    [Abstract] [Full Text] [Related]

  • 9. Monofunctional platinum(ii) anticancer complexes based on multidentate phenanthridine-containing ligand frameworks.
    Lozada IB, Huang B, Stilgenbauer M, Beach T, Qiu Z, Zheng Y, Herbert DE.
    Dalton Trans; 2020 May 26; 49(20):6557-6560. PubMed ID: 32342084
    [Abstract] [Full Text] [Related]

  • 10. Two new monofunctional platinum(II) dithiocarbamate complexes: phenanthriplatin-type axial protection, equatorial-axial conformational isomerism, and anticancer and DNA binding studies.
    Imran M, Rehman ZU, Hogarth G, Tocher DA, Chaudhry GE, Butler IS, Bélanger-Gariepy F, Kondratyuk T.
    Dalton Trans; 2020 Nov 10; 49(43):15385-15396. PubMed ID: 33140800
    [Abstract] [Full Text] [Related]

  • 11. Monofunctional platinum-DNA adducts are strong inhibitors of transcription and substrates for nucleotide excision repair in live mammalian cells.
    Zhu G, Myint M, Ang WH, Song L, Lippard SJ.
    Cancer Res; 2012 Feb 01; 72(3):790-800. PubMed ID: 22180496
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Monofunctional platinum(II) compounds and nucleolar stress: is phenanthriplatin unique?
    McDevitt CE, Yglesias MV, Mroz AM, Sutton EC, Yang MC, Hendon CH, DeRose VJ.
    J Biol Inorg Chem; 2019 Sep 01; 24(6):899-908. PubMed ID: 31494760
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Guanine nucleobase adducts formed by [Pt(di-(2-picolyl)amine)Cl]Cl: evidence that a tridentate ligand with only in-plane bulk can slow guanine base rotation.
    Andrepont C, Marzilli PA, Marzilli LG.
    Inorg Chem; 2012 Nov 05; 51(21):11961-70. PubMed ID: 23094695
    [Abstract] [Full Text] [Related]

  • 17. Structural and mechanistic studies of polymerase η bypass of phenanthriplatin DNA damage.
    Gregory MT, Park GY, Johnstone TC, Lee YS, Yang W, Lippard SJ.
    Proc Natl Acad Sci U S A; 2014 Jun 24; 111(25):9133-8. PubMed ID: 24927576
    [Abstract] [Full Text] [Related]

  • 18. The chiral potential of phenanthriplatin and its influence on guanine binding.
    Johnstone TC, Lippard SJ.
    J Am Chem Soc; 2014 Feb 05; 136(5):2126-34. PubMed ID: 24417436
    [Abstract] [Full Text] [Related]

  • 19. Click-Capable Phenanthriplatin Derivatives as Tools to Study Pt(II)-Induced Nucleolar Stress.
    O'Dowd PD, Guerrero AS, Alley KR, Pigg HC, O'Neill F, Meiller J, Hobbs C, Rodrigues DA, Twamley B, O'Sullivan F, DeRose VJ, Griffith DM.
    ACS Chem Biol; 2024 Apr 19; 19(4):875-885. PubMed ID: 38483263
    [Abstract] [Full Text] [Related]

  • 20. Cisplatin and phenanthriplatin modulate long-noncoding RNA expression in A549 and IMR90 cells revealing regulation of microRNAs, Wnt/β-catenin and TGF-β signaling.
    Monroe JD, Moolani SA, Irihamye EN, Lett KE, Hebert MD, Gibert Y, Smith ME.
    Sci Rep; 2021 May 17; 11(1):10408. PubMed ID: 34001990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.